Mednax Free Cash Flow vs End Period Cash Flow Analysis

MD Stock

USD 14.09 0.16 1.12%

Mednax financial indicator trend analysis is infinitely more than just investigating Mednax Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mednax Inc is a good investment. Please check the relationship between Mednax Free Cash Flow and its End Period Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Free Cash Flow vs End Period Cash Flow

Free Cash Flow vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mednax Inc Free Cash Flow account and End Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Mednax's Free Cash Flow and End Period Cash Flow is -0.24. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Mednax Inc, assuming nothing else is changed. The correlation between historical values of Mednax's Free Cash Flow and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Mednax Inc are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Free Cash Flow i.e., Mednax's Free Cash Flow and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

End Period Cash Flow

Most indicators from Mednax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mednax Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

At present, Mednax's Discontinued Operations is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 6.9 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.11.

	2021	2022	2023	2024 (projected)
Gross Profit	513.2M	467.0M	421.6M	542.2M
Total Revenue	1.9B	2.0B	2.0B	1.5B

Gross Profit Total Revenue

Mednax fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock Total Equity	Common Stock	Other Liab	Other Assets
Total Assets		0.8	0.69	0.64	0.86	-0.16	0.86	0.74	0.83	0.0	0.98	-0.09	-0.01	0.95	0.59	0.85	0.17	0.82	0.85	0.1	0.42	-0.33	0.67	0.71	0.63	0.22
Short Long Term Debt Total	0.8		0.36	0.56	0.38	-0.31	0.92	0.25	0.55	0.37	0.7	0.18	0.37	0.78	0.1	0.99	-0.11	0.65	0.99	0.26	0.67	0.0	0.55	0.57	0.73	0.48
Other Current Liab	0.69	0.36		0.42	0.72	0.01	0.38	0.63	0.34	0.01	0.67	-0.19	0.02	0.55	0.66	0.44	0.26	0.7	0.45	-0.08	0.28	-0.18	0.58	0.6	0.48	-0.48
Total Current Liabilities	0.64	0.56	0.42		0.45	0.39	0.53	0.28	0.36	0.16	0.58	-0.46	0.16	0.71	0.62	0.6	0.4	0.8	0.64	0.25	0.49	0.2	0.59	0.6	0.56	0.31
Total Stockholder Equity	0.86	0.38	0.72	0.45		0.03	0.55	0.95	0.82	-0.34	0.91	-0.3	-0.35	0.78	0.75	0.45	0.31	0.63	0.46	-0.08	0.03	-0.56	0.49	0.53	0.31	-0.05
Property Plant And Equipment Net	-0.16	-0.31	0.01	0.39	0.03		-0.29	0.05	-0.3	-0.14	-0.13	-0.92	-0.14	-0.16	0.22	-0.31	0.36	-0.1	-0.3	-0.07	-0.17	0.12	-0.34	-0.34	-0.24	-0.16
Net Debt	0.86	0.92	0.38	0.53	0.55	-0.29		0.45	0.71	-0.02	0.84	0.09	-0.02	0.89	0.15	0.92	-0.25	0.63	0.92	0.24	0.35	-0.13	0.53	0.55	0.69	0.52
Retained Earnings	0.74	0.25	0.63	0.28	0.95	0.05	0.45		0.8	-0.43	0.82	-0.37	-0.44	0.65	0.65	0.31	0.25	0.43	0.31	-0.3	-0.12	-0.76	0.3	0.34	0.06	-0.09
Accounts Payable	0.83	0.55	0.34	0.36	0.82	-0.3	0.71	0.8		-0.27	0.86	0.0	-0.28	0.83	0.5	0.59	0.09	0.52	0.6	-0.07	0.1	-0.63	0.5	0.54	0.25	0.39
Cash	0.0	0.37	0.01	0.16	-0.34	-0.14	-0.02	-0.43	-0.27		-0.2	0.27	1.0	-0.14	-0.11	0.35	0.3	0.17	0.35	0.08	0.9	0.3	0.15	0.16	0.23	0.0
Non Current Assets Total	0.98	0.7	0.67	0.58	0.91	-0.13	0.84	0.82	0.86	-0.2		-0.14	-0.21	0.95	0.59	0.76	0.1	0.75	0.76	0.07	0.23	-0.4	0.61	0.65	0.56	0.2
Non Currrent Assets Other	-0.09	0.18	-0.19	-0.46	-0.3	-0.92	0.09	-0.37	0.0	0.27	-0.14		0.28	-0.08	-0.4	0.16	-0.35	-0.04	0.15	0.31	0.2	0.17	0.22	0.2	0.23	0.15
Cash And Short Term Investments	-0.01	0.37	0.02	0.16	-0.35	-0.14	-0.02	-0.44	-0.28	1.0	-0.21	0.28		-0.14	-0.12	0.35	0.28	0.18	0.34	0.14	0.9	0.32	0.16	0.17	0.25	0.0
Net Receivables	0.95	0.78	0.55	0.71	0.78	-0.16	0.89	0.65	0.83	-0.14	0.95	-0.08	-0.14		0.55	0.82	0.05	0.83	0.84	0.18	0.31	-0.21	0.71	0.74	0.67	0.4
Common Stock Shares Outstanding	0.59	0.1	0.66	0.62	0.75	0.22	0.15	0.65	0.5	-0.11	0.59	-0.4	-0.12	0.55		0.2	0.67	0.74	0.25	-0.12	0.18	-0.25	0.56	0.58	0.23	-0.22
Non Current Liabilities Total	0.85	0.99	0.44	0.6	0.45	-0.31	0.92	0.31	0.59	0.35	0.76	0.16	0.35	0.82	0.2		-0.06	0.72	1.0	0.23	0.68	-0.03	0.62	0.64	0.75	0.43
Other Current Assets	0.17	-0.11	0.26	0.4	0.31	0.36	-0.25	0.25	0.09	0.3	0.1	-0.35	0.28	0.05	0.67	-0.06		0.35	-0.03	-0.15	0.36	-0.2	0.13	0.16	-0.16	-0.13
Other Stockholder Equity	0.82	0.65	0.7	0.8	0.63	-0.1	0.63	0.43	0.52	0.17	0.75	-0.04	0.18	0.83	0.74	0.72	0.35		0.76	0.23	0.55	0.08	0.86	0.86	0.74	0.11
Total Liab	0.85	0.99	0.45	0.64	0.46	-0.3	0.92	0.31	0.6	0.35	0.76	0.15	0.34	0.84	0.25	1.0	-0.03	0.76		0.25	0.68	-0.01	0.66	0.68	0.77	0.44
Property Plant And Equipment Gross	0.1	0.26	-0.08	0.25	-0.08	-0.07	0.24	-0.3	-0.07	0.08	0.07	0.31	0.14	0.18	-0.12	0.23	-0.15	0.23	0.25		0.2	0.59	0.28	0.22	0.61	0.29
Total Current Assets	0.42	0.67	0.28	0.49	0.03	-0.17	0.35	-0.12	0.1	0.9	0.23	0.2	0.9	0.31	0.18	0.68	0.36	0.55	0.68	0.2		0.2	0.47	0.49	0.51	0.16
Short Term Debt	-0.33	0.0	-0.18	0.2	-0.56	0.12	-0.13	-0.76	-0.63	0.3	-0.4	0.17	0.32	-0.21	-0.25	-0.03	-0.2	0.08	-0.01	0.59	0.2		0.11	0.07	0.45	0.01
Common Stock Total Equity	0.67	0.55	0.58	0.59	0.49	-0.34	0.53	0.3	0.5	0.15	0.61	0.22	0.16	0.71	0.56	0.62	0.13	0.86	0.66	0.28	0.47	0.11		0.99	0.7	0.08
Common Stock	0.71	0.57	0.6	0.6	0.53	-0.34	0.55	0.34	0.54	0.16	0.65	0.2	0.17	0.74	0.58	0.64	0.16	0.86	0.68	0.22	0.49	0.07	0.99		0.69	0.08
Other Liab	0.63	0.73	0.48	0.56	0.31	-0.24	0.69	0.06	0.25	0.23	0.56	0.23	0.25	0.67	0.23	0.75	-0.16	0.74	0.77	0.61	0.51	0.45	0.7	0.69		0.15
Other Assets	0.22	0.48	-0.48	0.31	-0.05	-0.16	0.52	-0.09	0.39	0.0	0.2	0.15	0.0	0.4	-0.22	0.43	-0.13	0.11	0.44	0.29	0.16	0.01	0.08	0.08	0.15

Click cells to compare fundamentals

Mednax Account Relationship Matchups

Mednax fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.1B	3.3B	2.7B	2.3B	2.2B	2.2B
Short Long Term Debt Total	1.8B	1.8B	1.1B	753.6M	701.6M	527.9M
Other Current Liab	(23.4M)	298.3M	300.3M	283.4M	256.2M	191.0M
Total Current Liabilities	511.9M	423.2M	394.1M	374.2M	388.9M	284.3M
Total Stockholder Equity	1.5B	747.7M	896.7M	891.6M	849.1M	1.2B
Property Plant And Equipment Net	82.8M	56.0M	65.5M	66.9M	145.9M	285.9M
Net Debt	1.7B	680.9M	678.4M	743.7M	628.4M	431.5M
Retained Earnings	510.2M	(286.4M)	(155.4M)	(89.1M)	(149.5M)	(142.0M)
Accounts Payable	511.9M	59.8M	36.6M	31.9M	34.6M	32.9M
Cash	112.8M	1.1B	387.4M	9.8M	73.3M	89.9M
Non Current Assets Total	3.5B	1.8B	2.0B	2.0B	1.7B	1.9B
Non Currrent Assets Other	(162.4M)	107.4M	(88.3M)	(105.9M)	82.2M	86.3M
Cash And Short Term Investments	112.8M	1.2B	387.4M	9.8M	177.7M	106.1M
Net Receivables	498.9M	241.9M	301.8M	296.8M	279.9M	228.1M
Common Stock Shares Outstanding	83.5M	83.4M	85.8M	84.1M	82.2M	77.1M
Liabilities And Stockholders Equity	4.1B	3.3B	2.7B	2.3B	2.2B	2.2B
Non Current Liabilities Total	2.1B	2.2B	1.4B	1.1B	981.8M	731.0M
Other Current Assets	45.4M	78.7M	51.7M	28.1M	25.8M	39.1M
Other Stockholder Equity	987.9M	1.0B	1.0B	983.6M	999.9M	695.6M
Total Liab	2.6B	2.6B	1.8B	1.5B	1.4B	982.2M
Property Plant And Equipment Gross	177.3M	132.2M	70.2M	73.3M	288.6M	303.1M
Total Current Assets	657.0M	1.5B	740.8M	334.8M	483.5M	382.4M
Accumulated Other Comprehensive Income	78K	3.5M	1.3M	(3.7M)	(2.2M)	(2.3M)
Short Term Debt	23.4M	42.3M	44.3M	60.5M	59.5M	62.5M
Common Stock Total Equity	842K	856K	864K	829K	953.4K	643.9K
Common Stock	842K	856K	864K	829K	840K	655.1K
Other Liab	330.2M	372.4M	365.9M	348.7M	401.0M	421.0M
Other Assets	1.8B	217.8M	219.4M	229.1M	263.5M	212.4M
Intangible Assets	274.4M	26.6M	21.6M	18.5M	21.2M	20.2M
Property Plant Equipment	129.1M	76.2M	70.2M	73.3M	84.3M	64.4M
Long Term Debt	1.7B	1.7B	1.0B	636.4M	611.6M	643.8M
Good Will	3.1B	1.7B	1.8B	1.8B	1.4B	2.2B
Short Term Investments	74.5M	104.9M	99.7M	93.2M	104.5M	109.7M
Net Tangible Assets	(9.4M)	(757.1M)	896.5M	891.6M	1.0B	1.1B
Long Term Debt Total	1.7B	1.7B	1.0B	636.4M	731.8M	1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

How To Invest In Mednax

Details

Is Mednax Stock a good investment?

Details

What is Mednax's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.11)

Earnings Share

(2.34)

Revenue Per Share

24.174

Quarterly Revenue Growth

0.009

Return On Assets

0.0467

The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mednax Free Cash Flow vs End Period Cash Flow Analysis

Free Cash Flow vs End Period Cash Flow

Free Cash Flow vs End Period Cash Flow Correlation Analysis

Correlation Coefficient

Free Cash Flow

End Period Cash Flow

Mednax fundamental ratios Correlations

Mednax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mednax fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Common Stock	+ 0.99	Common Stock Total Equity
Non Current Assets Total	+ 0.98	Total Assets

Non Currrent Assets Other	- 0.92	Property Plant And Equipment Net
Short Term Debt	- 0.76	Retained Earnings
Short Term Debt	- 0.63	Accounts Payable
Short Term Debt	- 0.56	Total Stockholder Equity
Other Assets	- 0.48	Other Current Liab
Non Currrent Assets Other	- 0.46	Total Current Liabilities